[Abstract] [Full Text PDF] (in Japanese / 1718KB) [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 88(9): 1225-1227, 1987


Report on the annual meeting

SURGICAL THERAPY FOR PRIMARY LUNG CANCER WITH PLEURAL CARCINOMATOSIS PARTICULARLY ON PANPLEUROPNEUMONECTOMY

*) The 2nd Department of Surgery, Niigata University School of Medicine, Niigata, Japan
**) Division of Thoracic Surgery, Niigata Prefectural Cancer Center Niigata Hospital, Niigata, Japan
***) Department of Surgery, National Nishi-Niigata Hospital, Niigata, Japan

Teruaki Koike*), Tatsuhiko Hirono*), Tsuneyo Takizawa*), Shoji Eguchi*), Masanori Terashima**), Akira Yamaguchi**), Makoto Iizuka***)

Seventy-five patients of primary lung cancer with pleural carcinomatosis were reviewed.
Three types of surgery were performed according to the staging of lung cancer : Panpleuropneumonectomy in eight cases ; lobectomy or pneumonectomy with or without partial pleurectomy in 28 cases ; exploratory thoracotomy in 39 cases.
Three out of eight patients with panpleuropneumonectomy survived more than 4 years. One of them was squamous cell carcinoma, and the others were adenocarcinoma. The staging factor of all three was cytologically negative pleural effusion and pNOMO.
The cumultive survival at two years was 17% in patients with exploratory thoractomy, 28% in patients with lobectomy or pneumonectomy and 60% in patients with papnpleuropneumonectomy.
Consequently, panpleuropneumonectomy should be performed on adenocarcinoma or squamous cell carcinoma cases with cytologically negative pleural effusion and pNOMO.


<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.